Comparison of treatment outcome between first‐line combination immunotherapy (anti‐PD‐L1 or anti‐PD1) with or without chemotherapy and chemotherapy alone in advanced non‐small cell lung cancer patients in tertiary care hospital

Comparison of treatment outcome between first‐line combination immunotherapy (anti‐PD‐L1 or anti‐PD1) with or without chemotherapy and chemotherapy alone in advanced non‐small cell lung cancer patients in tertiary care hospital

Abstract Background Despite promising outcomes of first‐line immunotherapy with or without chemotherapy in advanced non‐small cell lung cancer (NSCLC), limited accessibility due to reimbursement was remain the problem in low to middle income countries. This study aimed to evaluate real‐world effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Danainut Naratornsirakul, Busyamas Chewaskulyong, Sarawut Kongkarnka, Songporn Oranratnachai
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Cancer Medicine
Subjects:
anti‐Pd1 immunotherapy
anti‐PD‐L1
immunotherapy
non‐small cell lung cancer
Online Access:https://doi.org/10.1002/cam4.70007
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items